CLINICAL_TRIALS
trial_result
· 2020-07-17
Clinical Trial Update: Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. [Phase 1, Phase 2]
Summary
A completed Phase 1/2 trial evaluating topical ivermectin for reducing inflammatory markers in rosacea; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Rosacea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-17